Dun & Bradstreet stock rating cut to market perform by Raymond James

Raymond James downgraded Dun & Bradstreet (DNB) to market perform following shareholder approval of its acquisition by Clearlake Capital for $9.15 per share, a deal valuing DNB at $7.7 billion and expected to close in Q3 2025. The downgrade reflects the view that a more favorable outcome for shareholders is unlikely now that the transaction is effectively finalized. Concurrently, Jefferies also downgraded DNB to Hold with a price target of $9.15, and Clearlake Capital is securing $5.5 billion in debt financing led by Ares Management to support the acquisition.

Analysis

Dun & Bradstreet (NYSE:DNB) is set to be acquired by Clearlake Capital for $9.15 per share, a transaction valued at $7.7 billion, following shareholder approval which effectively finalizes the deal. This development has prompted analyst downgrades: Raymond James shifted its rating from 'strong buy' to 'market perform,' citing diminished prospects for a more favorable shareholder outcome, while Jefferies moved from 'Buy' to 'Hold,' adjusting its price target to the acquisition price of $9.15. Despite these rating changes, Raymond James has not altered its financial estimates for DNB, which reports strong gross profit margins of 62%. The acquisition, expected to close in Q3 2025, will see DNB transition to a privately-held company and its stock delisted. Clearlake Capital is securing $5.5 billion in debt financing, including a $5 billion term loan and a $500 million revolving credit facility led by Ares Management (NYSE:ARES) and supported by Morgan Stanley, to facilitate the purchase. While a 30-day "go-shop" period allows DNB to seek superior offers, the analyst actions and an external AI-driven valuation assessment suggesting DNB was not a top pick for significant upside imply that the $9.15 per share offer is likely the concluding price. This acquisition also involves a merger with Denali Intermediate Holdings, Inc., as part of the transaction structure.

Key Decisions for Investors

• Given the approved acquisition at $9.15 per share and subsequent analyst downgrades reflecting this price, existing Dun & Bradstreet shareholders should anticipate limited further price appreciation beyond the agreed terms.
• Investors should monitor the 30-day "go-shop" period for any potential superior offers, although current analyst sentiment and external valuation indicators suggest a low probability of a higher bid materializing.
• With the transaction expected to close in Q3 2025, holding shares until completion essentially locks in the $9.15 per share price, contingent on the deal successfully closing and subject to the time value of money.